Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. Reply
- PMID: 40239083
- DOI: 10.1056/NEJMc2502454
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. Reply
Comment on
-
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.N Engl J Med. 2025 Jan 23;392(4):361-371. doi: 10.1056/NEJMoa2406674. N Engl J Med. 2025. PMID: 39842011 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources